HBV'de Tedavi - EKMUD

10. Jackson LA, Janoff EN. Pneumococcal vaccination of
elderly adults: new paradigms for protection. Clin Infect
Dis 2008;47:1328-38.
11. Johnstone J, Marrie TJ, Eurich DT, Majumdar SR. Effect of
pneumococcal vaccination in hospitalized adults with
community-acquired pneumonia. Arch Intern Med
2007;167:1938-43.
12. Johnstone J, Eurich DT, Minhas JK, Marrie TJ, Majumdar
SR. Impact of the pneumococcal vaccine on long-term
morbidity and mortality of adults at high risk for pneumonia.
Clin Infect Dis 2010;51:15-22.
13. Macleod CM, Hodges RG, Heidelberger M, Bernhard
WG. Prevention of pneumococcal pneumonia by immunization
with specific capsular polysaccharides. J Exp Med
1945;82:445-65.
Hakan Erdem
14. Moberley SA, Holden J, Tatham DP, Andrews RM.
Vaccines for preventing pneumococcal infection in adults.
Cochrane Database Syst Rev 2008(1):CD000422.
15. Ortqvist A, Hedlund J, Burman LA, Elbel E, Hofer M,
Leinonen M, et al. Randomised trial of 23-valent pneumococcal
capsular polysaccharide vaccine in prevention
of pneumonia in middle-aged and elderly people.
Swedish Pneumococcal Vaccination Study Group. Lancet
1998;351:399-403.
16. Vila-Corcoles A, Ochoa-Gondar O, Hospital I, Ansa X,
Vilanova A, Rodriguez T, et al. Protective effects of the
23-valent pneumococcal polysaccharide vaccine in the
elderly population: the EVAN-65 study. Clin Infect Dis
2006;43:860-8.
3. Türkiye EKMUD Bilimsel Platformu 119